'More Is Not Better' in Two First-Line Trials for Biliary Tract Cancer

(MedPage Today) -- SAN FRANCISCO -- More therapy, whether cytotoxic or targeted, failed to improve outcomes in two separate randomized trials of front-line treatment for advanced biliary-tract cancer. The SWOG 1815 trial showed that adding nab...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news